hmpgloballearningnetwork.com
FDA Approves Both SC and IV Guselkumab for Crohn's Disease Among Adult Patients
Cure8 flagged this item because the article title and available source metadata connect it to Crohn's disease, Guselkumab, IL-23 inhibitor, and Medications. We do not yet have enough reliable article text to summarize the details.
This may be most useful for Adult patients following Crohn's disease, Guselkumab, IL-23 inhibitor, and Medications.
What To Know
Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be a regulatory update related to Crohn's disease, Guselkumab, IL-23 inhibitor, and Medications. Use the original source link for the full details.
The original article from hmpgloballearningnetwork.com has the full details, including any study limitations or source context.